Skip to the beginning of the images gallery

Roche's Acquisition of Genentech

Baldwin, Carliss Y. ; Becker, Bo ; Dessain, Vincent

Reference: HBS-210040-E
Year: Event Year Start:2008
Number of pages: 32
Geographic Setting: Geographic Setting:Switzerland
Publication Date: Feb 26, 2010
Fecha de edición: Sep 28, 2011
Source: HBSP (USA)
Type of Document: Case
Industry Setting: Industry Setting:Biotechnology;Pharmaceuticals

Grouped product items
Format	Language	Reference	Use	Qty	Price
pdf	English	HBS-210040-E			As low as €8.20

You already have a subscription

To order please contact the person in charge of academic purchases in your university.

You'll be able to order once your profile has been validated.

Description

Franz Humer, CEO of the Roche Group, must decide whether to mount a hostile tender offer for the publicly-owned shares of Roche's biotechnology subsidiary, Genentech. The case provides opportunities to analyze Roche's strategy with respect to Genentech, t

Keywords

Corporate governance Corporate strategy Mergers & acquisitions Tender offers